Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1047 results about "Benzofuran" patented technology

Benzofuran is the heterocyclic compound consisting of fused benzene and furan rings. This colourless liquid is a component of coal tar. Benzofuran is the "parent" of many related compounds with more complex structures. For example, psoralen is a benzofuran derivative that occurs in several plants.

Advantageous benzofuran compositions for mental disorders or enhancement

Pharmaceutically active benzofuran compositions for the treatment of mental disorders or for mental enhancement, including for entactogenic therapy. The present invention also includes benzofuran compounds, compositions, and methods for generally modulating central nervous system activity and treating central nervous system disorders.
Owner:TACTOGEN INC

Polycyclic compound containing triphenyl silicon and polyalkyl substituent and organic electroluminescent device containing polycyclic compound

The invention belongs to the technical field of OLEDs, and provides a polycyclic compound containing triphenyl silicon and a polyalkyl substituent group and an organic electroluminescent device containing the polycyclic compound. The structural general formula of the polycyclic compound is as shown in formula I in the specification. Benzofuran with higher electronegativity is introduced to a ring structure composed of nitrogen atoms and boron atoms, triphenyl silicon is introduced to the para-position of boron, and the synergistic effect of benzofuran and triphenyl silicon can significantly enhance the multiple resonance of a light-emitting core and reduce vibration relaxation. Due to simultaneous use of the benzofuran and the triphenyl silicon, the problems of vibration relaxation increase, spectrum widening and the like caused by introduction of the polyalkyl substituent are remarkably improved, the luminous efficiency of the material is remarkably improved, and the color purity is improved, so that the requirement of BT.2020 wide color gamut display standard on a luminescent spectrum is met. I
Owner:SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO LTD

TRPM3-modulating benzofuran derivatives

PCT designated stage expiredWO2025111414A1Organic chemistryAntipyreticPharmacologyEpilepsy
The invention relates to compounds that are useful for the prevention or treatment of TRPM3 mediated disorders, more in particular disorders including pain, inflammatory pain or inflammatory hypersensitivity, and epilepsy. The invention also relates to a method for the prevention or treatment of said TRPM3 mediated disorders.
Owner:KATHOLIEKE UNIV LEUVEN +1

Benzofuranone compound as well as pharmaceutical composition and application thereof

The invention provides a benzofuranone compound as well as a pharmaceutical composition and application thereof, and relates to the technical field of medicines. The benzofuranone compound is a compound as shown in a formula I, a stereoisomer thereof, a tautomer thereof, a crystalline hydrate thereof, a solvate thereof, a prodrug thereof or a pharmaceutically acceptable salt thereof. The benzofuranone compound and the pharmaceutical composition and the pharmaceutical preparation prepared from the benzofuranone compound can prevent or treat organ injury diseases, and have good treatment effects in kidney injury, liver injury, lung injury, brain injury and heart injury.
Owner:HANG ZHOU YUHONG PHARMATECH CO LTD

Organic compound containing phenanthrene benzofuran, organic electroluminescent device containing organic compound, display device and lighting device

The invention discloses an organic compound containing phenanthrene benzofuran, and an organic electroluminescent device, a display device and a lighting device comprising the same. The structural general formula of the organic compound is as shown in formula I; wherein L1 and L2 each independently represent any one of a single bond and an arylene group with a carbon atom number of C6-C12; ar1 represents a substituted or unsubstituted aryl group having a carbon atom number of C6-C60; ar2 represents a group represented by formula II, and ring A represents phenanthryl. By introducing a phenanthrene benzofuran substituent substituted by a specific site into the structure, the molecular high-energy linear state energy level can be adjusted while the molecular polarity is adjusted, and the carrier injection and energy level difference are improved, so that the internal quantum efficiency of the material is improved. And the phenanthrene benzofuran substituent at the specific site and anthryl present a rigid structure, which is beneficial for ordered arrangement of molecules according to a certain orientation, so that the light extraction efficiency is improved, and the device performance can be significantly improved. I; iI
Owner:SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO LTD

Ferulic acid derivative based on protein targeted degradation chimera as well as preparation method and application of ferulic acid derivative

ActiveCN118930519Afast drug effectImprove pharmacological activityOrganic active ingredientsOrganic chemistryAlkaneIsobenzofuran
The invention belongs to the field of biological medicine, and particularly relates to a ferulic acid derivative based on a protein targeted degradation chimera as well as a preparation method and application of the ferulic acid derivative. 3-aminopiperidine-2, 6-diketone and 4-fluoroisobenzofuran-1, 3-diketone are used as raw materials to prepare a compound 1, the compound a reacts with three alkane chains (b1-b3) and three PEG chains (b4-b6) in the presence of DIPEA to obtain compounds c1-c6, then the compounds c1-c6 react in the presence of trifluoroacetic acid to obtain d1-d6, and the compound d1-d6 is synthesized through a one-step synthesis method. And finally reacting with ferulic acid to obtain the ferulic acid derivative of the protein targeted degradation chimera. The ferulic acid derivative based on the targeted protein degradation chimera technology provided by the invention has higher pharmacological activity than a prototype medicine, and the pharmacological effect of the prototype medicine of a traditional Chinese medicine monomer is effectively improved; the ferulic acid derivative provided by the invention is simple in preparation process, easily available in materials, low in cost and easy to popularize, and has a good application prospect in the aspect of modifying and optimizing the structure of a traditional Chinese medicine monomer.
Owner:SHANDONG UNIV OF TRADITIONAL CHINESE MEDICINE

Organic compound, composition, electronic device, and display panel

The invention discloses an organic compound, a composition, an electronic device and a display panel. The organic compound has a structure as shown in formula (1): (1); the organic compound provided by the invention is an arylamine compound taking dibenzofuran or dibenzothiophene substituted by a heterocyclic group containing a nitrogen atom, an oxygen atom or a sulfur atom as a core structure, and can have a relatively high refractive index; when the organic compound provided by the invention is used in a covering layer of an electronic device, the refractive index of the covering layer can be effectively improved, so that the luminous efficiency of the electronic device is improved, and the electronic device with excellent performance can be realized.
Owner:GUANGZHOU CHINARAY OPTOELECTRONICS MATERIALS LTD

PARP / CK2 alpha double-target kinase inhibitor small molecule as well as pharmaceutical composition and application of PARP / CK2 alpha double-target kinase inhibitor small molecule

The invention discloses a novel PARP / CK2 double-target kinase inhibitor small molecule as well as a pharmaceutical composition and application thereof, the small molecule takes benzofuran pyrimidone as a parent drug effect ring and a benzene ring as a connector in drug design, and is coupled with a 1-amino-2-methylisothiourea group, so that the novel PARP / CK2 double-target kinase inhibitor is obtained. The compound has good inhibitory activity on exogenous PARP enzyme, exogenous CK2 alpha enzyme and proliferation activity of various cancer cells, and can be used for preparing antitumor drugs. # imgabs0 #
Owner:SOUTHEAST UNIV

Organic electroluminescent material as well as preparation method and application thereof

The invention belongs to the field of organic electroluminescence, and discloses an organic electroluminescence material as well as a preparation method and application thereof. The structure of the organic electroluminescent material is as shown in a chemical formula I: # imgabs0 #. According to the organic electroluminescent material compound provided by the invention, an aryl-substituted dibenzofuran group and a triarylamine group are bridged through a naphthylene group to form a mother nucleus main body, the rigid dibenzofuran structure can effectively enhance the structural stability, and the existence of the triarylamine group can improve the hole transport efficiency of the material; furthermore, the naphthylene group is bridged between the two main body structures, so that a more efficient conjugated system can be formed, the electron mobility of the whole material is improved, and the device has high luminous efficiency and long service life, and can maintain lower driving voltage at the same time.
Owner:JILIN OPTICAL & ELECTRONICS MATERIALS CO LTD +1

High-color-purity near-ultraviolet heat exciton compound with circular polarization property and application of high-color-purity near-ultraviolet heat exciton compound in preparation of circular polarization organic electroluminescent device

The invention discloses a high-color-purity near ultraviolet heat exciton compound with circular polarization property and application thereof in preparation of a circular polarization organic electroluminescent device, and belongs to the technical field of organic photoelectric materials. The electroluminescent material disclosed by the invention is a high-color-purity near ultraviolet heat exciton compound with circular polarization property, and two pairs of near ultraviolet enantiomers are successfully designed and synthesized by combining a chiral group binaphthol, a weak donor dibenzothiophene, dibenzofuran and an acceptor cyanophenyl; the compounds show obvious circular polarization luminescence property and high fluorescence quantum yield. The electroluminescent devices prepared based on the enantiomers all show near ultraviolet emission, CIE coordinates are respectively (0.168, 0.040) and (0.166, 0.040), and the external quantum efficiencies are respectively 4.3% and 3.4%. According to the near ultraviolet heat exciton material, a new visual angle is provided for developing the near ultraviolet heat exciton material with circular polarization luminescence and high color purity at the same time, and 3D and wide color gamut display can be directly achieved in the future.
Owner:JILIN UNIVERSITY

Benzofuran terphenyl HIF inhibitor as well as preparation method and application thereof

The invention relates to application of a benzofuran terphenyl compound in medicines, belongs to the field of medicinal chemistry, and particularly relates to a terphenyl compound which comprises a stereoisomer, a geometric isomer, a tautomer, nitrogen oxide, hydrate, solvate, metabolite and ester of the terphenyl compound. The pharmaceutically acceptable salt or the prodrug thereof and the pharmaceutical composition containing the compound are used as medicines, especially used for treating and / or preventing related diseases caused by HIF.
Owner:OCEAN UNIV OF CHINA

Preparation method and application of novel benzofuran component in eupatorium chinense

ActiveCN118994069AOrganic active ingredientsOrganic chemistryDiseaseProtein Tyrosine Phosphatase 1B
The invention discloses a preparation method and application of a novel benzofuran component in eupatorium chinense. The compound is obtained by being separated from an extraction part of the eupatorium chinense. The eupatorium chinense root extract is separated by using an extraction method, macroporous adsorption resin impurity removal, HW-40F gel column chromatography, high performance liquid chromatography and other methods to obtain a new benzofuran compound. The inhibitory activity of the separated compound on diabetes related targets alpha-glucosidase and protein tyrosine phosphatase 1B (PTP1B) is tested, the experimental result shows that the compound has good inhibitory activity on two enzymes, and the molecular docking experiment also shows that the compound has good inhibitory activity on the two enzymes. The compound has good binding energy with two target proteins alpha-glucosidase and protein tyrosine phosphatase 1B, so that the compound can be used for preparing drugs for preventing, delaying or treating alpha-glucosidase or PTP1B-mediated diseases, especially type II diabetes and obesity, or can be used as a lead compound of the drugs.
Owner:CHINA THREE GORGES UNIV

Preparation and application of NCOA4-targeting benzofuran [2, 3-b] pyridine derivative

The invention belongs to the technical field of medicinal chemistry, and discloses a preparation method and application of a benzofuran [2, 3-b] pyridine derivative of a targeted nuclear receptor co-activator 4 (NCOA4). The derivative has a structural general formula as shown in the following formula (I), wherein R1, R2 and R3 substituent groups can be combined at will. The compounds are combined with NCOA4 to interfere the cell iron autophagy process and effectively inhibit the ferroptosis of various cells induced by RSL3 or Erastin. Particularly, the binding affinity of the compound 4k and NCOA4 is optimal (Kd is equal to 0.78 mu M), and the compound 4k has remarkable ferroptosis inhibition activity and can be used for research and development of medicines for ferroptosis-related diseases. # imgabs0 #
Owner:CHONGQING MEDICAL UNIVERSITY

Novel benzofuran component in eupatorium chinense and application of benzofuran component in anti-inflammatory activity

The invention discloses a novel benzofuran component in eupatorium chinense and application of the benzofuran component in anti-inflammatory activity. The obtained compound is separated from an eupatorium chinense extract. The eupatorium chinense root extract is separated by using an extraction method, macroporous adsorption resin impurity removal, Sephadex LH-20 gel column chromatography, high performance liquid chromatography and other methods. According to the present invention, all the separated compounds and the analogues thereof have good inhibition activity on target cyclooxygenase-2 of inflammation-related diseases, and have good inhibition activity on COX-2 enzyme, and the molecular docking experiment results show that the compounds and the target proteins have good binding energy. Therefore, the compound can be used for preparing drugs for treating inflammatory related diseases, or anti-inflammatory and analgesic drugs, or tumor drugs by inhibiting COX-2 enzyme, such as drugs for rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, Alzheimer's disease and the like, and related natural lead compounds are provided.
Owner:CHINA THREE GORGES UNIV

Blue light-emitting compound containing dibenzofuran structure, composition containing blue light-emitting compound and organic electroluminescent device

ActiveCN119039336ABlocking the effects of excitation/emission processesImprove half width of luminescenceGroup 3/13 element organic compoundsLuminescent compositionsPhenyl groupMaterials science
The invention discloses a blue light-emitting compound containing a dibenzofuran structure, a composition containing the blue light-emitting compound and an organic electroluminescent device. The structural general formula of the blue light-emitting compound is shown as a formula I-1 or a formula I-2, and L1 and L2 independently represent phenylene or biphenylene. According to the blue light-emitting compound provided by the invention, the spacer group is added between the diaryl benzofuran structure and an MR-TADF multiple resonance plane, so that the influence of a dibenzofuran fragment on multiple resonance can be remarkably weakened, and the material light-emitting half-peak width is improved. Besides, after dibenzofuran fragments are used in both the guest material and the light-emitting host material, due to the mutual repulsive interaction of oxygen atom lone pair electrons, the intermolecular distance is increased, and the adverse effect of Dexter energy transfer on the light-emitting efficiency of the device is reduced. # imgabs0 # I-1; and # imgabs1 # I-2.
Owner:SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO LTD

Organometallic compound and organic electroluminescent device containing same

The invention provides an organic metal compound and an organic light-emitting device comprising the same, and belongs to the field of organic photoelectric materials, the organic metal compound has a structure shown in a general formula I. The organic metal compound has a structure shown in a general formula I by changing the combination of substituent groups on 2-(dibenzo [b, d] furan-4-yl) pyridine, and the organic light-emitting device with the organic metal compound can be obtained by synthesizing 2-(dibenzo [b, d] furan-4-yl) pyridine. The organic metal compound is generated by adding-CN,-F, branched alkyl, substituted or non-substituted aryl and substituted or non-substituted naphthenic base, intermolecular spatial configuration is improved, the organic metal compound has good space twisting capability, carrier migration is avoided, and after the organic metal compound serves as a specific doping material of a luminescent layer and is applied to an organic electroluminescent device, the organic electroluminescent device has high luminous efficiency. The driving voltage of the device is reduced, so that carrier migration is avoided, the driving voltage is obviously reduced, the luminous efficiency is obviously improved, and the service life is obviously prolonged.
Owner:JILIN OPTICAL & ELECTRONICS MATERIALS CO LTD

Method for producing 2, 3-dihydrobenzofuran through solvent-free catalytic hydrogenation

The invention relates to a synthesis method for preparing 2, 3-dihydrobenzofuran in a formula I. The synthesis method comprises the following steps: under a solvent-free condition and under the catalysis of a catalyst palladium carbon, carrying out a reduction reaction on a compound as shown in a formula 2 and hydrogen: # imgabs0 #. The reaction conditions are mild, the operation is easy, the yield is high, the cost is low, the environmental pollution is small, the obtained product is good in quality, and the method is suitable for industrial production. The economic benefit is relatively high.
Owner:菏泽皓元医药科技有限公司

1-chloro-8-fluoro-7-isopropyl benzofuro [2, 3-c] pyridine and synthetic method and application thereof

The invention relates to the technical field of organic synthesis, in particular to 1-chloro-8-fluorine-7-isopropyl benzofuro [2, 3-c] pyridine as well as a synthesis method and an application of the 1-chloro-8-fluorine-7-isopropyl benzofuro [2, 3-c] pyridine. According to the invention, 1-chloro-8-fluoro-7-isopropyl benzofuro [2, 3-c] pyridine and nanogold are cooperated to cover the surface of a glassy carbon electrode (GCE), and a novel electrochemical modified electrode AuNPs / 1 / GCE is developed. The modified glassy carbon electrode shows good selectivity, high stability and sensitivity and wide detection range on the detection of the antibiotic furacilin.
Owner:SHANGHAI LONGSHENG CHEM CO LTD

Flame-retardant expandable polystyrene and method for producing the same

ActiveCN116622116BPolystyreneFire retardant
The application discloses a kind of flame-retardant expandable polystyrene and its preparation method.It includes the following raw materials: styrene, nucleating agent, desalted water, organic compound containing peroxide functional group, inorganic salt, bromine flame retardant, dispersant, solvent.The product powder and bulk material prepared by the application are less, and the prepared polystyrene board has excellent mechanical properties.After one week or even one month, no collapse, deformation and other phenomena occur, the combustion performance completely reaches B level, and has efficient flame-retardant fireproof performance.Meanwhile, the product obtained by the application has high bromine content, good thermal stability, low bleeding, no toxicity, little influence on material mechanical properties, and no toxic gas such as polybrominated dibenzo-p-dioxin and polybrominated dibenzofuran is produced during thermal cracking or combustion, which completely meets the requirements of European dioxin regulations and does not harm the environment.
Owner:TIANJIN JIATAI WEIYE CHEM IND CO LTD

Preparation of 1-dihydrobenzofuran-3-aryl-2-pyrazole-propenone and application of 1-dihydrobenzofuran-3-aryl-2-pyrazole-propenone as antitumor drug

The invention relates to a novel compound as well as a preparation method and application thereof, in particular to (Z / E)-1-(2, 2-dimethyl-2, 3-dihydrobenzofuran-5-yl)-3-aryl-2-(1H-pyrazol-1-yl)-2-propylene-1-ketone as well as a preparation method and application thereof in preparation of an anti-tumor drug, and discloses a preparation method of (Z / E)-1-(2, 2-dimethyl-2, 3-dihydrobenzofuran-5-yl)-3-aryl-2-(1H-pyrazol-1-yl)-2-propylene-1-ketone. The structural formula of the compound 1-(2, 2-dimethyl-2, 3-dihydrobenzofuran-5-yl)-3-aryl-2-(1H-pyrazol-1-yl)-2-propylene-1-ketone is as shown in a formula I or a formula II: # imgabs 0 #, and the structural formula of the compound 1-(2, 2-dimethyl-2, 3-dihydrobenzofuran-5-yl)-3-aryl-2-(1H-pyrazol-1-yl)-2-propylene-1-ketone is as shown in a formula II. Wherein R1 is selected from a methoxy group, an ethyoxyl group or a propoxy group; r1 is selected from methyl, methoxy, ethyoxyl, nitro, iodine, bromine, chlorine, fluorine, 2, 4-difluoro, 2, 4-dichloro, 2, 3, 4-trichloro, 2, 4-dimethoxy and 2, 3, 4-trimethoxy, and R2 is selected from methyl, methoxy, ethyoxyl, nitro, iodine, bromine, chlorine, fluorine, 2, 4-difluoro, 2, 4-dichloro, 2, 3, 4-trichloro, 2, 4-dimethoxy and 2, 3, 4-trimethoxy.
Owner:HEBEI UNIVERSITY

2-benzylbenzofuran and diaryl acetone compounds or pharmaceutically acceptable salts thereof and application of 2-benzylbenzofuran and diaryl acetone compounds or pharmaceutically acceptable salts thereof

The invention relates to the field of medicines, and particularly provides 2-benzylbenzofuran and diaryl acetone compounds which are separated from a traditional Chinese medicine argillaceae and have a novel structure or pharmaceutically acceptable salts thereof, and application of the 2-benzylbenzofuran and diaryl acetone compounds or pharmaceutically acceptable salts thereof in myocardial protection. And a good myocardial protection effect is achieved.
Owner:BEIJING ZHENDONG GUANGMING PHARMA RES INST +1

Benzofuran salt morphic forms and mixtures for the treatment of mental disorders or mental enhancement

Salt morphic forms, morphic salt mixtures, and specified salt mixtures of pharmaceutically active benzofuran compositions are provided for the treatment of mental disorders or for mental enhancement, including for entactogenic therapy. The present invention also includes salt morphic forms, morphic salt mixtures, and specified salt mixtures of benzofuran compounds, compositions thereof, and methods for generally modulating central nervous system activity and treating central nervous system disorders.
Owner:TACTOGEN INC

Organic light-emitting device

The present invention relates to an organic light-emitting device employing, as a host of a light emission layer, an anthracene derivative compound having a characteristic structure by introduction of a benzofuran structure into the anthracene backbone, and as a dopant of the light emission layer, a polycyclic compound having a characteristic structure. The organic light-emitting device according to the present invention is an organic light-emitting device with significantly improved external quantum efficiency and can be advantageously utilized not only for lighting devices but also for various display devices, such as flat, flexible, and wearable displays.
Owner:SFC CO LTD

Organic metal iridium complex, preparation method thereof, luminescent material and organic electroluminescent device

The invention relates to the technical field of organic electroluminescent devices, in particular to an organic metal iridium complex, a preparation method of the organic metal iridium complex, a luminescent material and an organic electroluminescent device. The organic metal iridium complex is selected from a compound shown in the following structural formula: # imgabs0 #, wherein R1 to R14 are respectively and independently selected from any one of hydrogen, deuterium, tritium, halogen, cyano, trimethyl silicon, trimethyl germanium, substituted or unsubstituted C1-C10 alkyl, substituted or unsubstituted C3-C8 cycloalkyl, substituted or unsubstituted C6-C20 aryl and substituted or unsubstituted 4-membered to 8-membered heterocyclic radical; the number of R10 on a benzene ring of dibenzofuran in the formula 1 is 1 or 2; s1 is selected from substituted or unsubstituted dibenzofuran, and S1 is fused with any position on a benzene ring of adjacent dibenzofuran. The organic metal iridium complex is low in synthesis cost, simple in synthesis process and difficult to purify, and an organic electroluminescent device formed by the organic metal iridium complex is high in luminous efficiency, long in service life and low in driving voltage.
Owner:JILIN OPTICAL & ELECTRONICS MATERIALS CO LTD

Preparation and application of NiAl2O4-loaded Ni2P dehydrogenation catalyst

The invention belongs to the technical field of catalyst preparation, and particularly relates to a dehydrogenation catalyst which takes nickel aluminate spinel as a carrier and transition metal phosphide Ni2P as an active component, and the mass of the active component accounts for 5-20% of the total mass of the Ni2P / NiAl2O4 catalyst. The invention also provides a preparation method of the dehydrogenation catalyst, which comprises the following steps: preparing nickel aluminate spinel by adopting a coprecipitation method, then loading nickel salt and phosphorus salt onto the carrier, and drying, roasting and reducing to obtain the loaded Ni2P / NiAl2O4 catalyst. Compared with the prior art, the non-noble metal dehydrogenation catalyst prepared by the method is low in price, the preparation method is simple and easy to implement, and the non-noble metal dehydrogenation catalyst shows good reaction performance in a reaction for preparing benzofuran-2 (3H)-ketone through catalytic dehydrogenation and has potential industrial application prospects.
Owner:DALIAN INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES

Derivatives having 2,3-dihydro-1H-indene or 2,3-dihydrobenzofuran moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same

Provided are a compound having a 2,3-dihydro-1H-indene or 2,3-dihydrobenzofuran moiety or pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same and a use thereof, where the compound having a 2,3-dihydro-1H-indene or 2,3-dihydrobenzofuran moiety or pharmaceutically acceptable salt thereof has an inhibitory activity against glucosylceramide synthase (GCS), and therefore can be usefully applied for preventing or treating various diseases associated with GCS, such as Gaucher disease, Fabry disease, Tay-Sachs disease, Parkinson's disease, etc.
Owner:YUHAN CORPORATION +1